OBJECTIVE: Maternal sepsis is associated with high maternal and neonatal morbidity and mortality. However, characteristics associated with development of sepsis have not been described. The goal of this study was to examine predictors of maternal sepsis. STUDY DESIGN: This is a retrospective cohort study of all cases of antepartum maternal sepsis at time of delivery in California from [2005][2006][2007][2008] as recorded in the state birth certificate registry that is linked with statewide hospital discharge and death certificate data. Maternal sepsis was identified by ICD-9 codes and to focus on antepartum sepsis, we excluded associated codes of postpartum sepsis, endometritis, wound infection, and mastitis. Fetal anomalies and triplet gestations and higher were also excluded. Comparisons were made between cases of sepsis and all other births without a sepsis code, using chi-squared or Fisher's exact test, as appropriate. Multivariable logistic regression was performed adjusting for maternal age, parity, race/ethnicity, education, insurance status, degree of prenatal care, gestational age, and twin gestation. RESULTS: Of 2,250,129 deliveries, 688 (0.03%) cases of sepsis were identified. Listeriosis was rare, but most associated with development of sepsis (aOR 83.4, CI 16.9-410.8, p<0.001). More common, pyelonephritis and chorioamnionitis were both significantly associated with sepsis (aOR 63.3, CI 45.5-87.9, p<0.001 and aOR 10.5, CI 8.5-13.1, p<0.001). Maternal race was significantly associated with sepsis, with Asian/Pacific Islander (aOR 1.7, CI 1.3-2.2, p<0.001) and Hispanic (aOR 1.3, CI 1.0-1.6, p¼0.03) women at increased risk. Nulliparous women were at increased risk (aOR 1.5, CI 1.3-1.6, p<0.001), as were women with public insurance (aOR 1.3, CI 1.0-1.5, p¼0.17). CONCLUSION: In this cohort, chorioamnionitis, pyelonephritis, pneumonia, pancreatitis, listeriosis, and fungal infection were all significantly associated with developing sepsis. Asian/Pacific Islander and Hispanic women were at increased risk, as were women with public insurance. OBJECTIVE: Infection represents an increasingly frequent cause of severe maternal morbidity. However, the timing of postpartum infectious readmissions in the United States is not well defined. The objectives of this study were to characterize timing of and risk factors for postpartum infectious readmissions. STUDY DESIGN: Data from 2010 to 2014 from a nationally representative administrative readmissions database were utilized for this study. We identified readmissions within 60 days of delivery hospitalization discharge occurring for one of the following primary diagnoses: sepsis, breast infection, respiratory infection, genitourinary tract infection, endometritis, wound complication, and appendicitis. We evaluated time interval from discharge to readmission for all infections. Multivariable log linear regression analysis was used to assess risk factors associated with 60-day readmission for infection. A sensitivity analysis was performed excluding patients with infection diagnosed at time of delivery. RESULTS: 15.7 million delivery hospitalizations were included in the analysis. 81,080 60-day readmissions for infectious causes were identified. Infectious readmission was most common 11-20 days after delivery discharge with 43% of readmissions occurring during this 10-day period (Figure) . 286,054 (1.8%) of women had an infection diagnosed during their delivery hospitalization; these women were more than twice as likely to be readmitted with an infection (Table) . Women at highest risk for infectious readmission were those with cesarean delivery, postpartum hemorrhage (with and without transfusion), Medicare and Medicaid insurance, and systemic lupus (Table) . Results were similar in the sensitivity analysis excluding patients with delivery hospitalization infection. CONCLUSION: Infection is a common indication for postpartum readmission. With risk for readmission highest 10-20 days after ajog.org
Risk factors and temporality for postpartum infection readmissions
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619 Mechanical dilation in HIV positive subjects does not increase risk of histologic chorioamnionitis OBJECTIVE: Chorioamnionitis is a risk factor for perinatal HIV transmission and early-onset neonatal sepsis. Placental inflammation increases risk of HIV transmission. The objective of this study is to explore the risk of histologic chorioamnionitis in HIV-1 positive subjects undergoing induction of labor with and without mechanical dilation. STUDY DESIGN: This is a multi-center retrospective cohort study of HIV positive women who underwent induction/augmentation of labor from 11/2010 e 8/2017 at two major tertiary care centers in different states. Delivery outcomes including: histologic and clinical chorioamnionitis, postpartum endometritis, and neonatal HIV infection were included for analysis. A bivariate analysis of demographic, HIV specific, and delivery outcome measures between the cohorts was conducted. Multivariate logistical regression modeling was used to control for possible confounding variables. RESULTS: A total of 396 HIV+ women delivered during the study period. 135 women met inclusion criteria and 95 had placental pathology available for review. 83 women (61.5%) underwent mechanical dilation and 51 (38.5%) had no mechanical dilation. The cohorts were similar in terms of race/ethnicity, age, parity, HIV viral load, CD4 count, and GBS status. The mechanical dilation cohort had less cervical dilation on admission compared to the control. 20 subjects had histologic chorioamnionitis (21.05%). There was no difference in rates of histologic chorioamnionitis between the cohorts with 14 (22.22%) of the mechanical dilation cohort and 6 OBJECTIVE: Elective cesarean delivery has been shown to decrease vertical mother-to-child transmission (MTCT) of HIV in women with viral load (VL) >1000 copies/mL. HIV+ women who present late in pregnancy may not have viral load quantification prior to delivery. Our study investigated the costs and outcomes of using a point-of-care (POC) HIV RNA VL test to inform mode of delivery versus cesarean section for all (CS all) in HIV+ pregnant women without prenatal care. STUDY DESIGN: A decision-analytic model was constructed using TreeAge software to compare Xpert HIV-1 VL test versus CS all in HIV+ women without prenatal care who presented at term for delivery. We used a theoretical cohort of 1,275 women, the estimated population of HIV+ women without prenatal care in the US annually. The average cost per Xpert test for our cohort was $15.03. We assumed all women proceeded to a second delivery with undetectable VL, reflecting the average number of births per US woman. Primary outcomes included neonatal HIV transmission, mode of delivery, and cesarean-related complications, in addition to cost and quality-adjusted life years (QALYs). All probabilities, costs, and utilities were derived from literature and varied using sensitivity analyses. A cost-effectiveness threshold was set at $100,000/QALY. RESULTS: In our theoretical cohort, quantifying VL to guide mode of delivery resulted in more HIV+ neonates as compared to immediate CS all (Table) . The increased rate of MTCT in this strategy results from fewer cesarean deliveries. There were no observed maternal deaths or differences in cesarean-related complications, including hysterectomy and uterine rupture, between the two strategies. Quantifying VL prior to delivery would increase cost by $3,142,940 and decrease QALYs by 74 as compared to CS all in the setting of unknown VL. The rapid VL test requires 99.9% sensitivity in order to be cost-effective. With the threshold set at $100,000/QALY, the POC HIV RNA VL test is cost-effective only when the proportion of women with high VL is below 12% (Figure) . CONCLUSION: For HIV+ pregnant women without prenatal care in the US, utilizing a POC HIV RNA VL test to guide mode of delivery is not cost-effective when compared to CS for all women even when including the downstream impact of a cesarean delivery. Our model underscores the importance of prenatal antiretroviral treatment to decrease MTCT. Additionally, POC HIV RNA VL tests require greater examination and study in obstetric populations.
